Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Santa Ana Tellez, Yared ^a   Mantel Teeuwisse, Aukje K ^a   Dreser, Anahi ^b   Leufkens, Hubert G M ^a   Wirtz, Veronika J ^b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; NON PRESCRIPTION DRUG; PENICILLIN DERIVATIVE; SULFONAMIDE;

ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG CONTROL; DRUG LEGISLATION; DRUG USE; DRUG UTILIZATION; MEXICO;

ANTI-BACTERIAL AGENTS; BRAZIL; DRUG UTILIZATION; HUMANS; MEXICO; NONPRESCRIPTION DRUGS; PRESCRIPTION DRUG MISUSE;

EID: 84885724094     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075550     Document Type: Article

References (23)

1. Diekema DJ, Brueggemann B, Doern GV, (2000) Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. Emerging infectious diseases 6: 552-556 doi:10.3201/eid0605.000519.
2. Goossens H, Ferech M, Vander Stichele R, Elseviers M, (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579-587 doi:10.1016/S0140-6736(05)17907-0.
3. Pan American Health Organization (2004) Legislación sobre antibióticos en América Latina. Washington, D.C. Available: http://www1.paho.org/spanish/ad/dpc/cd/amr-legis.pdf. Accessed 2013 March 2.
4. Bavestrello L, Cabello A, Casanova D (2002) [Impact of regulatory measures in the trends of community consumption of antibiotics in Chile]. Revista médica de Chile 130: 1265-1272. Available: http://www.ncbi.nlm.nih.gov/pubmed/12587509. Accessed 2013 April 17.
5. Bavestrello FL, Cabello MÁ, (2011) Consumo comunitario de antimicrobianos en Chile, 2000-2008. Revista chilena de infectología 28: 107-112 doi:10.4067/S0716-10182011000200001.
6. Wirtz VJ, Herrera-Patino JJ, Santa-Ana-Tellez Y, Dreser A, Elseviers M, et al. (2013) Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries. Tropical medicine & international health□: TM & IH. doi:10.1111/tmi.12096.
7. Wirtz VJ, Dreser A, Gonzales R, (2010) Trends in antibiotic utilization in eight Latin American countries, 1997-2007. Revista panamericana de salud pública = Pan American journal of public health 27: 219-225.
8. Dreser A, Wirtz VJ, Corbett KK, Echániz G (2008) Uso de antibióticos en México: revisión de problemas y políticas. Salud Pública de México 50: S480-S487. Available: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36342008001000009&lng=en&nrm=iso&tlng=en. Accessed 2013 April 17.
9. Dreser A, Vázquez-Vélez E, Treviño S, Wirtz VJ, (2012) Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC public health 12: 1051 doi:10.1186/1471-2458-12-1051.
10. Diario Oficial de la Federacinó(2010) Acuerdo por el que se determinan los lineamientos a los que estará sujeta la venta y dispensación de antibióticos. Available: http://dof.gob.mx/nota_detalle.php?codigo=5144336&fecha=27/05/2010. Accessed 2012 November 17.
11. IMS Health (2006) Pharmerging shake-up. Available: http://www.imshealth.com/ims/Global/Content/Insights/Featured Topics/Emerging Markets/Pharma_Shake-up_Imperatives.pdf. Accessed 2013 April 2.
12. Pfarma (n.d.) Pfarma. Available: http://pfarma.com.br/noticia-setor-farmaceutico/legislacao-farmaceutica/387-rdc-44-2010-antibioticos.html. Acessed 2013 April 4.
13. ANVISA (2010) Resolução da Diretoria Colegiada - RDC N° 44, de 26 de Outubro de 2010. 26/10/10. Available: http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2010/res0044_26_10_2010.html. Accessed 2012 December 11.
14. ANVISA (2013) Definida nova data para controle eletrônico de antibióticos. 17/01/2013. Available: http://portal.anvisa.gov.br/wps/content/anvisaportal/anvisa/saladeimprensa/menu-noticiasanos/2013noticias/definidanovadataparacontroleeletronicodeantibioticos. Accessed 2013 April 18.
15. Pan American Health Organization (1999) Prevention and Control of Antimicrobial Resistance. Available: http://www1.paho.org/English/AD/DPC/CD/RegionalPlanParaguay.pdf. Acessed 2013 March 21.
16. World Health Organization Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health, (Intitution O (2012) ATC/DDD Index. 2012. Available: http://www.whocc.no/atc_ddd_index/. Accessed 2012 November 12.
17. Pan American Health Organization (n.d.) Pan American Health Organization Data Tabulator. Available: http://www.paho.org/English/SHA/coredata/tabulator/newTabulator.htm. Accessed 2012 November 12.
18. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D, (2002) Segmented regression analysis of interrupted time series studies in medication use research. Journal of clinical pharmacy and therapeutics 27: 299-309.
19. Chipman JS, (1979) Efficiency of Least-Squares Estimation of Linear Trend when Residuals Are Autocorrelated. Econometrica 47: 115-128.
20. StataCorp (2011) Stata Statistical Software: Release 12.
21. Health IMS (2008) Pharmaceutical Market, Mexico and Brazil. London.
22. ANVISA (2012) Sistema de gerenciamento de produtos controlados completa cinco anos de funcionamento. 30/03/2012. Available: http://portal.anvisa.gov.br/wps/content/anvisaportal/anvisa/saladeimprensa/menu-noticiasanos/2012noticias/sistemadegerenciamentodeprodutoscontroladoscompletacincoanosdefuncionamento. Accessed 2013 April 1.
23. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, et al. (2006) European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. The Journal of antimicrobial chemotherapy 58: 401-407. Available: http://www.ncbi.nlm.nih.gov/pubmed/16735414. Accessed 2013 April 4.